Assenagon Asset Management S.A. Sells 16,175 Shares of Ovid Therapeutics Inc. (NASDAQ:OVID)
Assenagon Asset Management S.A. lowered its holdings in Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) by 18.7% in the ...
Barclays PLC Has $98,000 Holdings in Ovid Therapeutics Inc. (NASDAQ:OVID)
Barclays PLC boosted its holdings in shares of Ovid Therapeutics Inc. (NASDAQ:OVID – Free Report) by 311.2% in the third quarter, according to its most recent filing with the Securities and Exchange ...